• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.65% Nasdaq Down 1.89%

    Seattle Genetics Inc. (SGEN)

    -NasdaqGS
    33.20 Up 0.18(0.55%) Jan 27, 4:00PM EST
    |After Hours : 32.77 Down 0.43 (1.30%) Jan 27, 4:36PM EST
    Add to Portfolio
    Prev Close:33.02
    Open:32.67
    Bid:N/A
    Ask:34.26 x 1000
    1y Target Est:46.00
    Beta:2.34
    Next Earnings Date:10-Feb-15SGEN Earnings announcement
    Day's Range:32.56 - 33.66
    52wk Range:30.05 - 55.99
    Volume:987,971
    Avg Vol (3m):1,361,200
    Market Cap:4.11B
    P/E (ttm):N/A
    EPS (ttm):-0.53
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SGEN

    Comparison

    Symbol% ChgMkt Cap
    SGENUp 0.55%4.11B
    IMGNDown 0.62%552.56M
    PFEDown 0.61%205.40B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):14.62
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.66
    Quarterly EPS Est (Dec-14) :-0.25
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):-4.95

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Seattle Genetics, Inc., a biotechnology company, develops and commercializes antibody-based therapies for the treatment of cancer. The company is developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback